Sutro Biopharma (STRO) Profit After Tax Growth (3y) (2020 - 2025)
Sutro Biopharma (STRO) Profit After Tax Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,538.84 Bn | 65,538.56 Bn | - | 9.53% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 469.46 Bn | 464.67 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 122.69 Bn | 115.45 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 70.41 Bn | 61.65 Bn | 3.31 Bn | -27.65% |
| 7 | Belite Bio | 62.84 Bn | 62.84 Bn | - | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn | 70.25% |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn | 47.10% |
| 10 | Sutro Biopharma | 200.34 Mn | 58.91 Mn | - | -10.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.57% |
| Sep 30, 2025 | -42.89% |
| Jun 30, 2025 | 23.82% |
| Mar 31, 2025 | -24.77% |
| Dec 31, 2024 | -23.86% |
| Sep 30, 2024 | -16.44% |
| Jun 30, 2024 | -98.36% |
| Mar 31, 2024 | -24.24% |
| Dec 31, 2023 | 36.11% |
| Sep 30, 2023 | -69.57% |
| Jun 30, 2023 | -48.72% |
| Mar 31, 2023 | -36.70% |
| Dec 31, 2022 | -32.75% |
| Sep 30, 2022 | -14.71% |
| Jun 30, 2022 | -23.55% |
| Mar 31, 2022 | -40.01% |
| Dec 31, 2021 | -194.48% |
| Sep 30, 2021 | -44.52% |
| Jun 30, 2021 | 18.92% |
| Mar 31, 2021 | -36.09% |